ATEC secures exclusive U.S. commercial rights to Theradaptive’s OsteoAdapt osteoinductive bone graft, currently in clinical trials for spinal and dental applications
Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding
Collaboration funds participating biotechs to access Lilly predictive models through the Revvity Signals Xynthetica offering
Valneva said regaining full rights to the vaccine will allow the company to “assume direct control over its supply chain and commercialization for endemic high-risk countries
The partnership also sets the stage for broader collaboration on rare disease treatments
For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows
Singlera and Pure Medical will team up with local universities, hospital networks, and national healthcare systems across Western Europe for research studies
Under the terms of the deal, AstraZeneca gains exclusive rights to JAB-23E73 outside of mainland China
NUFYMCO BLA has been approved by the USFDA
The new powder formulation gives children and adults living with Rett syndrome greater flexibility and choice in dose volume and taste
Subscribe To Our Newsletter & Stay Updated
